Five-Year Experience With Single-Agent Ibrutinib

Aditi Choudhry, MD Hematology Oncology Fellow UC Irvine presents the Five-Year Experience With Single-Agent Ibrutinib in Patients With Previously Untreated and
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia at the MOASC Spotlight on ASH 2017.